New Innovations for Patients with Brain Tumors
Neurosurgeons at Mayfield Brain & Spine use the most innovative techniques and technologies to care for patients with brain tumors. One of the latest examples is GammaTile therapy, a targeted radiation treatment. Mayfield is among a distinguished roster of national health systems using GammaTile therapy.
More than 200,000 U.S. patients are diagnosed each year with an aggressive brain tumor. Aggressive brain tumors often resist current treatments and have a high likelihood of recurrence. The GammaTile is implanted in the final stages of brain tumor removal surgery and provides immediate radiation therapy to a highly targeted area. The small collagen tile is placed directly at the site of the tumor immediately after the tumor is removed to target residual tumor cells before they can replicate. Because the therapy is implanted at the end of surgery, patients treated with GammaTile therapy require no additional trips to the hospital or clinic for radiation therapy.
GammaTile therapy received regulatory clearance from the U.S. Food and Drug Administration to treat recurrent brain tumors in July 2018. The FDA expanded its use in January 2020 to allow patients with newly diagnosed malignant brain tumors to receive the therapy. In February 2020, Mayfield neurosurgeon Dr. Vincent DiNapoli, Director of the Brain Tumor Center at The Jewish Hospital-Mercy Health, was the first in the country to use targeted GammaTile therapy for patients with newly diagnosed malignant brain tumors.
“GammaTile treatment for newly diagnosed brain tumors is a significant step forward for patients and an example of the benefits that focused neurosurgical research and clinical innovation can provide,” Dr. DiNapoli said. “The targeted radiation delivered by GammaTile will save lives and set the stage for further groundbreaking advances against brain tumors. At Mayfield, we are committed to that research and innovation and delighted to be colleagues with a distinguished roster of clinical providers.”
In recent months, Mayfield neurosurgeons have expanded the use of GammaTile to patients at Good Samaritan Hospital and The Christ Hospital. This enhanced access to innovative technology is another example of Mayfield leveraging its research and clinical expertise to benefit patients at different locations. Mayfield neurosurgeons who have performed the procedure include Dr. DiNapoli, Dr. Robert Bohinski, Dr. Yair Gozal, Dr. George Mandybur and Dr. Christopher McPherson.
GT Medical Technologies has identified five health systems that earned a place on its roster of Elite Distinguished Brain Tumor Specialists by performing at least 10 GammaTile procedures in 2020: Memorial Sloan Kettering Cancer Center, M Health Fairview, HonorHealth Scottsdale Osborn Medical Center, NorthShore University HealthSystem and Mayfield Brain & Spine.
“Providing GammaTile as an option to patients with brain tumors shows how Mayfield Brain & Spine’s expanded partnership with The Christ Hospital is benefiting patients and improving the health of our community,” said Dr. Bohinski, Mayfield neurosurgeon and Director of Neurosurgery at The Christ Hospital. “The targeted radiation treatment that GammaTile provides will increase effectiveness and reduce recovery times. Innovations like GammaTile make health care better.”
Mayfield’s innovation in GammaTile therapy is the latest way the neurosurgery practice works with multiple health systems to elevate the treatment of brain tumors and other cranial diseases and disorders for patients in Greater Cincinnati and around the country.
Both TriHealth’s Good Samaritan Hospital and the Jewish Hospital-Mercy Health have earned The Joint Commission’s Gold Seal of Approval for Brain Tumor Certification. The certification recognizes health care organizations that provide clinical programs across the continuum of care for brain tumors. Mayfield also joined with Mercy Health and OHC to create the new Brain Tumor Center at The Jewish Hospital.
In Northern Kentucky, St. Elizabeth Healthcare is ramping up its brain tumor capabilities, and new developments are on the horizon. Mayfield physicians work alongside St. Elizabeth Physicians to diagnose and treat adult patients with primary and metastatic brain tumors.
All three brain tumor programs support multidisciplinary Tumor Board conferences, where experts regularly discuss treatment and management strategies for common or rare brain tumors.
With the help of the neurosurgeons at Mayfield Brain & Spine, patients throughout the region can be confident that they will receive excellent and innovative treatment regardless of which hospital they visit.